Prognosis and management of membraneous nephropathy.

Simple item page
dc.contributor.authorPahari, D Ken_US
dc.contributor.authorDas, Sen_US
dc.contributor.authorDutta, B Nen_US
dc.contributor.authorBanerjee, Den_US
dc.date.accessioned1993-06-01en_US
dc.date.accessioned2009-05-31T05:06:35Z
dc.date.available1993-06-01en_US
dc.date.available2009-05-31T05:06:35Z
dc.date.issued1993-06-01en_US
dc.description.abstractPatients of idiopathic membranous nephropathy (MGN) were randomly assigned to received steroid and cyclophosphamide every other month (Gr-I) and steroid alone (Gr-II). Of 36 patients in Gr.I, 33 patients achieved complete remissions, 2 had relapsing course with remission on further courses of therapy and only one has reached end stage renal failure. In contrast, of the 35 patients in Gr. II, 15 (P < 0.001) achieved complete remission, 7 are in partial remission, 5 have no response, another 5 have deterioration of renal function of which two required dialysis, and 3 have relapsing course after the initial remission. Mean follow up period was 46 +/- 10.2 months. We conclude that steroid and cyclophosphamide every other month is highly effective in achieving remission in patients with membranous nephropathy.en_US
dc.description.affiliationDepartment of Medicine, Institute of Post Graduate Medical Education & Research, Calcutta.en_US
dc.identifier.citationPahari DK, Das S, Dutta BN, Banerjee D. Prognosis and management of membraneous nephropathy. Journal of the Association of Physicians of India. 1993 Jun; 41(6): 350-1en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/95307
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshCyclophosphamide --administration & dosageen_US
dc.subject.meshDose-Response Relationship, Drugen_US
dc.subject.meshDrug Administration Scheduleen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshGlomerulonephritis, Membranous --drug therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPrednisolone --administration & dosageen_US
dc.subject.meshPrognosisen_US
dc.titlePrognosis and management of membraneous nephropathy.en_US
dc.typeClinical Trialen_US
dc.typeComparative Studyen_US
dc.typeJournal Articleen_US
dc.typeRandomized Controlled Trialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Association of Physicians of India